These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 25162311)

  • 21. Targeting IL-17A/glucocorticoid synergy to CSF3 expression in neutrophilic airway diseases.
    Ouyang S; Liu C; Xiao J; Chen X; Lui AC; Li X
    JCI Insight; 2020 Feb; 5(3):. PubMed ID: 32051346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Characteristics of the airway inflammation and the relationship to interleukin-17 in severe asthma].
    Zhou QT; Sun YC; Yao WZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Sep; 28(9):630-4. PubMed ID: 16207434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steroid-insensitive ERK1/2 activity drives CXCL8 synthesis and neutrophilia by airway smooth muscle.
    Robins S; Roussel L; Schachter A; Risse PA; Mogas AK; Olivenstein R; Martin JG; Hamid Q; Rousseau S
    Am J Respir Cell Mol Biol; 2011 Nov; 45(5):984-90. PubMed ID: 21493783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement C3a-induced IL-17 plays a critical role in an IgE-mediated late-phase asthmatic response and airway hyperresponsiveness via neutrophilic inflammation in mice.
    Mizutani N; Goshima H; Nabe T; Yoshino S
    J Immunol; 2012 Jun; 188(11):5694-705. PubMed ID: 22539791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of airway inflammation in bronchial asthma.
    Nakagome K; Nagata M
    Auris Nasus Larynx; 2011 Oct; 38(5):555-63. PubMed ID: 21334836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What effect does asthma treatment have on airway remodeling? Current perspectives.
    Durrani SR; Viswanathan RK; Busse WW
    J Allergy Clin Immunol; 2011 Sep; 128(3):439-48; quiz 449-50. PubMed ID: 21752441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Th17-mediated inflammation in asthma.
    Newcomb DC; Peebles RS
    Curr Opin Immunol; 2013 Dec; 25(6):755-60. PubMed ID: 24035139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation.
    Jevnikar Z; Östling J; Ax E; Calvén J; Thörn K; Israelsson E; Öberg L; Singhania A; Lau LCK; Wilson SJ; Ward JA; Chauhan A; Sousa AR; De Meulder B; Loza MJ; Baribaud F; Sterk PJ; Chung KF; Sun K; Guo Y; Adcock IM; Payne D; Dahlen B; Chanez P; Shaw DE; Krug N; Hohlfeld JM; Sandström T; Djukanovic R; James A; Hinks TSC; Howarth PH; Vaarala O; van Geest M; Olsson H;
    J Allergy Clin Immunol; 2019 Feb; 143(2):577-590. PubMed ID: 29902480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The overexpression of heparin-binding epidermal growth factor is responsible for Th17-induced airway remodeling in an experimental asthma model.
    Wang Q; Li H; Yao Y; Xia D; Zhou J
    J Immunol; 2010 Jul; 185(2):834-41. PubMed ID: 20530256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutrophilic inflammation in severe persistent asthma.
    Jatakanon A; Uasuf C; Maziak W; Lim S; Chung KF; Barnes PJ
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1532-9. PubMed ID: 10556116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Th17 response to Dermatophagoides pteronyssinus is related to late-phase airway and systemic inflammation in allergic asthma.
    Bajoriuniene I; Malakauskas K; Lavinskiene S; Jeroch J; Sakalauskas R
    Int Immunopharmacol; 2013 Dec; 17(4):1020-7. PubMed ID: 24161744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BuShenYiQi Formula strengthens Th1 response and suppresses Th2-Th17 responses in RSV-induced asthma exacerbated mice.
    Wang J; Wu J; Kong L; Nurahmat M; Chen M; Luo Q; Li B; Wu X; Dong J
    J Ethnopharmacol; 2014 May; 154(1):131-47. PubMed ID: 24704667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Airway remodeling in asthma: new mechanisms and potential for pharmacological intervention.
    Girodet PO; Ozier A; Bara I; Tunon de Lara JM; Marthan R; Berger P
    Pharmacol Ther; 2011 Jun; 130(3):325-37. PubMed ID: 21334378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Severe asthma: new therapeutic targets].
    Aubier M
    Bull Acad Natl Med; 2010 Jun; 194(6):1009-19. PubMed ID: 21513135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis of severe asthma.
    Poon AH; Eidelman DH; Martin JG; Laprise C; Hamid Q
    Clin Exp Allergy; 2012 May; 42(5):625-37. PubMed ID: 22515387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What's new in asthma pathophysiology and immunopathology?
    Orihara K; Dil N; Anaparti V; Moqbel R
    Expert Rev Respir Med; 2010 Oct; 4(5):605-29. PubMed ID: 20923340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential involvement of IL-17F in asthma.
    Ota K; Kawaguchi M; Matsukura S; Kurokawa M; Kokubu F; Fujita J; Morishima Y; Huang SK; Ishii Y; Satoh H; Hizawa N
    J Immunol Res; 2014; 2014():602846. PubMed ID: 24829928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Augmented epithelial endothelin-1 expression in refractory asthma.
    Pégorier S; Arouche N; Dombret MC; Aubier M; Pretolani M
    J Allergy Clin Immunol; 2007 Dec; 120(6):1301-7. PubMed ID: 17996929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bronchial epithelium as a target for innovative treatments in asthma.
    Gras D; Chanez P; Vachier I; Petit A; Bourdin A
    Pharmacol Ther; 2013 Dec; 140(3):290-305. PubMed ID: 23880290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-17A and vascular remodelling in severe asthma; lack of evidence for a direct role.
    Panariti A; Baglole CJ; Sanchez V; Eidelman DH; Hussain S; Olivenstein R; Martin JG; Hamid Q
    Clin Exp Allergy; 2018 Apr; 48(4):365-378. PubMed ID: 29337379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.